Search Results
| No. |
VISDB ID▲▼ |
Virus Name▲▼ |
Subtype▲▼ |
Virus Genome▲▼ |
Breakpoint 1▲▼ |
Breakpoint 2▲▼ |
Human Genome▲▼ |
Chr▲▼ |
Start▲▼ |
End▲▼ |
Loci▲▼ |
Target Gene▲▼ |
Sample Type▲▼ |
Disease▲▼ |
Method▲▼ |
PubMed ID▲▼ |
Year▲▼ |
Curated Way▲▼ |
| 3261 |
TVIS20024591
|
Human Papillomavirus |
HPV16 |
K02718 |
7146 |
- |
hg38 |
chr20 |
14391576 |
14391576 |
p12.1 |
MACROD2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 3262 |
TVIS20024595
|
Human Papillomavirus |
HPV16 |
K02718 |
3040 |
- |
hg38 |
chr20 |
9252562 |
9252562 |
p12.2 |
PLCB4 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 3263 |
TVIS20024602
|
Human Papillomavirus |
HPV16 |
K02718 |
2899 |
- |
hg38 |
chr20 |
9267427 |
9267427 |
p12.2 |
PLCB4 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 3264 |
TVIS20024817
|
Human Papillomavirus |
HPV33 |
M12732 |
6163 |
- |
hg38 |
chr20 |
14112072 |
14112072 |
p12.1 |
MACROD2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 3265 |
TVIS20024846
|
Human Papillomavirus |
HPV33 |
M12732 |
6925 |
- |
hg38 |
chr20 |
54095482 |
54095482 |
q13.2 |
ENSG00000286587 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 3266 |
TVIS20024896
|
Human Papillomavirus |
HPV33 |
M12732 |
832 |
- |
hg38 |
chr20 |
48235455 |
48235455 |
q13.13 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 3267 |
TVIS20024906
|
Human Papillomavirus |
HPV33 |
M12732 |
4086 |
- |
hg38 |
chr20 |
5603849 |
5603849 |
p12.3 |
GPCPD1 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 3268 |
TVIS20025063
|
Human Papillomavirus |
HPV16 |
K02718 |
1046 |
- |
hg38 |
chr20 |
3921435 |
3921435 |
p13 |
ENSG00000275582, PANK2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 3269 |
TVIS20025065
|
Human Papillomavirus |
HPV16 |
K02718 |
1000 |
- |
hg38 |
chr20 |
55843708 |
55843708 |
q13.2 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 3270 |
TVIS20025069
|
Human Papillomavirus |
HPV16 |
K02718 |
740 |
- |
hg38 |
chr20 |
56882791 |
56882791 |
q13.31 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |